Character Biosciences logo — A patient-driven drug discovery platform for diseases of agi...

Character Biosciences

A patient-driven drug discovery platform for diseases of aging

Founded 2019 United States San Francisco, United States 36 employees Series A Total: $27.00M Biotechnology, Health Care +1

General Information

Company Name Character Biosciences
Founded Year 2019
Location United States San Francisco, United States
Founders / Decision Makers
Team member
Employees 36
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Character Biosciences. To contact Character Biosciences, visit characterbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Character Biosciences compare?

A PDF of Character Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Character Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Character Biosciences

Character Biosciences is a precision medicine platform with the slogan "A patient-driven drug discovery platform for diseases of aging." The company, formerly known as Clover Therapeutics, is focused on unlocking the patterns of age-related diseases in diverse populations. Founded in 2018, their mission is to use human genetics to understand the underlying causes of diseases with the aim of discovering targeted therapies for more effective treatments, particularly for patients lacking treatment options. Character Biosciences partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts and to enable clinical genomic research. Their approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify molecular drivers of disease progression and develop innovative targeted medicines. The company operates within the Biotechnology, Health Care, and Pharmaceutical industries and is based in the United States. Their most recent investment was a Series A investment on 2nd September 2022, with Shane Neman being the investor. Overall, Character Biosciences' focus on precision medicine, patient-centric approach, and innovative methodologies for drug discovery position them as a promising player in addressing diseases of aging through targeted therapies.

Business keywords: precision medicine, drug discovery, patient-driven, genomics, clinical research, therapeutics, aging diseases, molecular drivers, longitudinal data, patient cohorts, privacy, ethics, data security, patient health

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
Shane Neman
02 Sep 2022
Series A $18.00M 8
Casdin Capital, Industry Ventures +6
17 May 2022
Seed Round $6.00M 1
Casdin Capital
01 Apr 2020
Pre Seed Round $3.00M -
15 Sep 2019

Character Biosciences Alternatives & Competitors

View All Alternatives
Character Biosciences vs
IndyGeneUS Bio
IndyGeneUS Bio United States

Pioneering Longevity Solutions with the Power of the African Genome

Pre-Seed
13 employees
Biotechnology, Health Care
Character Biosciences vs
Paratus Sciences
Paratus Sciences United States

Translating evolutionary insights into first-in-class medicines

Series A
19 employees
Biotechnology, Health Care
Character Biosciences vs
MNM Bioscience
MNM Bioscience United States

From tumor genomes to AI-driven drug discovery

Seed
2 employees
AI, Biotechnology

FAQ About Character Biosciences

A patient-driven drug discovery platform for diseases of aging
Character Biosciences was founded in 2019.
Character Biosciences is headquartered in San Francisco, United States.
Character Biosciences operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on precision medicine, drug discovery, patient-driven and genomics.
Character Biosciences has approximately 36 employees.
Character Biosciences has completed 4 funding rounds, raising a total of $27.00M. The latest funding stage is Series A.
Top alternatives and competitors to Character Biosciences include IndyGeneUS Bio, Paratus Sciences, MNM Bioscience, PrecisionLife, Promedior. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Character Biosciences and IndyGeneUS Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Character Biosciences, https://bouncewatch.com/company/character-biosciences, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes